Capital infusion in public sector banks undershoots market expectations —BUDGET–: The Economic Times

Clipped from: https://economictimes.indiatimes.com/industry/banking/finance/banking/budget-capital-infusion-in-public-sector-banks-undershoots-market-expectations/articleshow/80629575.cms?utm_source=ETTopNews&utm_medium=HPTN&utm_campaign=AL1&utm_content=23

Advertorial

CILICANT stays ahead of the pack with the launch of their third manufacturing facility

Synopsis

CILICANT has become one of the world’s trusted brands in active pharmaceutical packaging. The company manufactures a range of high-quality solutions which are designed to protect products from the harmful effects of moisture and oxidation.

Leading active packaging firm, CILICANT, has announced the launch of its third manufacturing facility in Pune; increasing its manufacturing capacity threefold in order to meet increasing demand. Since its launch in 2011, Cilicant has gone from strength to strength and has solidified its place as a market leader in the manufacture of active pharmaceutical packaging. With a focus on superior quality products, meticulous safety standards and state of the art technology, Cilicant has opened the doors to its third facility despite the difficult market conditions presented by the pandemic.

https://www.youtube.com/embed/643iv5JlvXg
Founded by Manish Jain, an industry professional with over three decades of experience in the desiccants industry, in 2011, CILICANT has become one of the world’s trusted brands in active pharmaceutical packaging. The company manufactures a range of high-quality solutions which are designed to protect products from the harmful effects of moisture and oxidation.

Outstanding quality and superior safety
The new cGMP compliant facility in Pune has been launched to support Cilicant’s end-to-end production and distribution operations. It will increase the company’s production of pharmaceutical and medical devices by three times whilst maintaining Cilicant’s commitment to outstanding quality. Quality assurance is a matter of pride for Cilicant and, as such, both raw materials and finished products are tested per US pharmacopoeia standards using high tech instruments – all within Cilicant’s own in-house Quality Control laboratory.

Safety first
With health and safety more important than ever, each and every Cilicant employee receives continuous training to ensure that safety standards and regulatory best practices are strictly adhered to. All Cilicant products are manufactured in a classified cleanroom using the latest technology and adhering to industry best practices.

CILICANT founder, Mr Manish Jain, says, “Continuous improvement has always been the crux of CILICANT’s growth. With the launch of our new state of the art manufacturing facility, we intend to continue with the same ethos that we started with – outstanding quality and superior safety standards. We thank our customers who have not only supported us, but have inspired us to be the best that we can be. It is due to the loyalty and support of our customers that we have achieved this incredible milestone.”

CILICANT Sales Director, Mr Sumeet Sharma adds, “the opening of the new manufacturing facility is an important step towards realising our goals in meeting and surpassing the current market demand for desiccants.. This third manufacturing facility will be the first of many important changes to be made in line with our unwavering high-quality standards and will allow us to continue to offer the quality and service that our customers have come to expect from us. This facility is expected to increase sales of desiccants and will allow us to capture the major share of the desiccant market for the year 21-22. The facility will primarily serve all of pharmaceutical clients based in India to meet the increased requirements of the regulated market. Our sales team is incredibly excited at the prospect of being able to serve our clients – and the industry – even more effectively with the addition of the new facility.’’

CILICANT Marketing Director, Fahmim Hussain says, “Since its inception, Cilicant has envisioned itself not only as an active packaging manufacturing company but as a dynamic Indian brand which is capable of being global. The establishment of the third manufacturing facility is just another feather in the cap and we hope to have many more of these in the coming years in order to fulfil our goal of becoming a global brand.”

Cilicant is dedicated to quality assurance and is a holder of DMF with USFDA and Health Canada and is ISO 15378:2017 certified.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s